Japan Expects To Begin Making H1N1 Vaccine Early In June
This article was originally published in PharmAsia News
Executive SummaryJapan's Health, Labor and Welfare Ministry says the country may be ready in a few weeks to begin making vaccines against the H1N1 flu virus. The proper strain of the virus was on its way from the United States, the minister said, and would be put into production as soon as the government decides how much production to divide between the H1N1 flu and seasonal flu. Four drug makers already are producing vaccines against the seasonal flu expected this coming winter. But the second wave of infections from this past season, including that of the new flu, is expected in the fall. (Click here for more
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.